November 29, 2018 - Diagnosing Zika in the field presents specific challenges as other diseases, such as chikungunya and dengue, present in the same areas, can give a false positive on diagnostic tests. Read more
November 23, 2018 - The mosquito Aedes aegypti should be considered one of the most dangerous animals on the planet. This is because the Aedes aegypti female carries several viruses that can cause diseases such as yellow fever, dengue and ... Read more
September 19, 2018 - On the 11 and 12of September, scientists from leading research organizations across the world met for the ZikaPLAN Consortium meeting at the London School of Hygiene & Tropical Medicine in the UK. Read more
July 9, 2018 - ZikaPLAN’s NEURO-ZIKA neurological manifestations working group leader, the University of Liverpool, has been working with another working group member, Fiocruz, and the Brazilian Ministry of Health, the Brazilian charities ‘Uniao de Maes dos Anjos-UMA’ (Recife), ‘Associação ... Read more
July 3, 2018 - NEURO-ZIKA pathogenesis work in ZikaPLAN is differentiating autoimmune versus direct neuropathic phenomena of ZIKV to impact both clinical care and basic understanding of disease. Read more
Matthews et al. – Nature, November 14, 2018
Progress in understanding the biology of Aedes aegypti mosquitoes and developing the tools to fight them has been slowed by the lack of a high-quality genome assembly. The authors of this study combine diverse technologies to produce a markedly improved, fully re-annotated AaegL5 genome assembly and demonstrate how it accelerates mosquito science to fight this deadly disease vector.
Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.
To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.
Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).
ZikaPLAN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734584.